Fast Depressive Symptom Improvement in Bipolar Disorder Type 1 after Stanford Accelerated Intelligent Neuromodulation Therapy: A Two-Site Feasibility and Safety Open Label Trial

Saved in:
Bibliographic Details
Main Authors: Jorge Almeida, Jennifer Siegel-Ramsay, Irving Reti, Nolan Williams, Brandon Bentzley, Kevin Li, Caitlin DuPont, Amy Bichlmeier, Alexa Comfort, Peter Zandi
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Brain Stimulation
Online Access:http://www.sciencedirect.com/science/article/pii/S1935861X24002407
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850239369613410304
author Jorge Almeida
Jennifer Siegel-Ramsay
Irving Reti
Nolan Williams
Brandon Bentzley
Kevin Li
Caitlin DuPont
Amy Bichlmeier
Alexa Comfort
Peter Zandi
author_facet Jorge Almeida
Jennifer Siegel-Ramsay
Irving Reti
Nolan Williams
Brandon Bentzley
Kevin Li
Caitlin DuPont
Amy Bichlmeier
Alexa Comfort
Peter Zandi
author_sort Jorge Almeida
collection DOAJ
format Article
id doaj-art-c8e96f2f5446466ca4d4686f762e7d15
institution OA Journals
issn 1935-861X
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Brain Stimulation
spelling doaj-art-c8e96f2f5446466ca4d4686f762e7d152025-08-20T02:01:10ZengElsevierBrain Stimulation1935-861X2025-01-0118122810.1016/j.brs.2024.12.045Fast Depressive Symptom Improvement in Bipolar Disorder Type 1 after Stanford Accelerated Intelligent Neuromodulation Therapy: A Two-Site Feasibility and Safety Open Label TrialJorge Almeida0Jennifer Siegel-Ramsay1Irving Reti2Nolan Williams3Brandon Bentzley4Kevin Li5Caitlin DuPont6Amy Bichlmeier7Alexa Comfort8Peter Zandi9The University of Texas at Austin, USAThe University of Texas at Austin, USAJohns Hopkins University, USAStanford University, USAMagnus Medical, USAJohns Hopkins University, USAJOHNS HOPKINS, USAThe University of Texas at Austin, USAJOHNS HOPKINS, USAJOHNS HOPKINS, USAhttp://www.sciencedirect.com/science/article/pii/S1935861X24002407
spellingShingle Jorge Almeida
Jennifer Siegel-Ramsay
Irving Reti
Nolan Williams
Brandon Bentzley
Kevin Li
Caitlin DuPont
Amy Bichlmeier
Alexa Comfort
Peter Zandi
Fast Depressive Symptom Improvement in Bipolar Disorder Type 1 after Stanford Accelerated Intelligent Neuromodulation Therapy: A Two-Site Feasibility and Safety Open Label Trial
Brain Stimulation
title Fast Depressive Symptom Improvement in Bipolar Disorder Type 1 after Stanford Accelerated Intelligent Neuromodulation Therapy: A Two-Site Feasibility and Safety Open Label Trial
title_full Fast Depressive Symptom Improvement in Bipolar Disorder Type 1 after Stanford Accelerated Intelligent Neuromodulation Therapy: A Two-Site Feasibility and Safety Open Label Trial
title_fullStr Fast Depressive Symptom Improvement in Bipolar Disorder Type 1 after Stanford Accelerated Intelligent Neuromodulation Therapy: A Two-Site Feasibility and Safety Open Label Trial
title_full_unstemmed Fast Depressive Symptom Improvement in Bipolar Disorder Type 1 after Stanford Accelerated Intelligent Neuromodulation Therapy: A Two-Site Feasibility and Safety Open Label Trial
title_short Fast Depressive Symptom Improvement in Bipolar Disorder Type 1 after Stanford Accelerated Intelligent Neuromodulation Therapy: A Two-Site Feasibility and Safety Open Label Trial
title_sort fast depressive symptom improvement in bipolar disorder type 1 after stanford accelerated intelligent neuromodulation therapy a two site feasibility and safety open label trial
url http://www.sciencedirect.com/science/article/pii/S1935861X24002407
work_keys_str_mv AT jorgealmeida fastdepressivesymptomimprovementinbipolardisordertype1afterstanfordacceleratedintelligentneuromodulationtherapyatwositefeasibilityandsafetyopenlabeltrial
AT jennifersiegelramsay fastdepressivesymptomimprovementinbipolardisordertype1afterstanfordacceleratedintelligentneuromodulationtherapyatwositefeasibilityandsafetyopenlabeltrial
AT irvingreti fastdepressivesymptomimprovementinbipolardisordertype1afterstanfordacceleratedintelligentneuromodulationtherapyatwositefeasibilityandsafetyopenlabeltrial
AT nolanwilliams fastdepressivesymptomimprovementinbipolardisordertype1afterstanfordacceleratedintelligentneuromodulationtherapyatwositefeasibilityandsafetyopenlabeltrial
AT brandonbentzley fastdepressivesymptomimprovementinbipolardisordertype1afterstanfordacceleratedintelligentneuromodulationtherapyatwositefeasibilityandsafetyopenlabeltrial
AT kevinli fastdepressivesymptomimprovementinbipolardisordertype1afterstanfordacceleratedintelligentneuromodulationtherapyatwositefeasibilityandsafetyopenlabeltrial
AT caitlindupont fastdepressivesymptomimprovementinbipolardisordertype1afterstanfordacceleratedintelligentneuromodulationtherapyatwositefeasibilityandsafetyopenlabeltrial
AT amybichlmeier fastdepressivesymptomimprovementinbipolardisordertype1afterstanfordacceleratedintelligentneuromodulationtherapyatwositefeasibilityandsafetyopenlabeltrial
AT alexacomfort fastdepressivesymptomimprovementinbipolardisordertype1afterstanfordacceleratedintelligentneuromodulationtherapyatwositefeasibilityandsafetyopenlabeltrial
AT peterzandi fastdepressivesymptomimprovementinbipolardisordertype1afterstanfordacceleratedintelligentneuromodulationtherapyatwositefeasibilityandsafetyopenlabeltrial